CNS disease prevalence is rising, and available treatments for many are either minimally effective or nonexistent. CNS is one of the primary therapeutic areas where we have chosen to focus efforts.
Read moreJulius Clinical’s focused approach has created a track record of excellence that testifies to our cardio-metabolic trial capabilities. We have honed our scientific site networks, collaborations with leading experts, and operational resources to deliver steady streams of patients and high-quality data for clients.
Read moreUnrecognised pathogens and reemerging infectious diseases are an ongoing threat to human health in every corner of the world. We contribute to important research in this area by conducting pioneering infectious disease and vaccine trials, doing what we do best: optimizing protocols and executing streamlined trials that deliver high-quality data.
Read moreCNS disease prevalence is rising, and available treatments for many are either minimally effective or nonexistent. CNS is one of the primary therapeutic areas where we have chosen to focus efforts.
Read moreJulius Clinical’s focused approach has created a track record of excellence that testifies to our cardio-metabolic trial capabilities. We have honed our scientific site networks, collaborations with leading experts, and operational resources to deliver steady streams of patients and high-quality data for clients.
Read moreUnrecognised pathogens and reemerging infectious diseases are an ongoing threat to human health in every corner of the world. We contribute to important research in this area by conducting pioneering infectious disease and vaccine trials, doing what we do best: optimizing protocols and executing streamlined trials that deliver high-quality data.
Read more
The upcoming NASH clinical webinar promises to be an insightful and informative session, with our scientific officer Manuel Castro Cabezas as the guest speaker. Manuel will be sharing his expertise on the topic of "Why NASH trials frequently fa...
On May 9, we presented the webinar: Selecting and successfully integrating cognitive testing into clinical trials During this webinar, hosted by Dr. Lieza Exalto, speaker Dr. John Harrison discussed: Cognitive domains – which ones sh...
We are excited to invite you to our webinar exploring the innovative integration of Real World Data (RWD) in clinical trials for Amyotrophic Lateral Sclerosis (ALS). As a critical step forward in the pursuit of effective treatments and improved pa...
"*" indicates required fields
"*" indicates required fields
